Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial
2018 ◽
Vol 21
(1)
◽
pp. 136-145
◽
Keyword(s):
2018 ◽
Vol 20
(9)
◽
pp. 2200-2209
◽
Keyword(s):
2013 ◽
Vol 14
(4)
◽
pp. 361-370
◽
2011 ◽
Vol 65
(9)
◽
pp. 930-938
◽
Keyword(s):
2013 ◽
Vol 15
(3)
◽
pp. 311-324
◽
2017 ◽
Vol 9
(8)
◽
pp. 719-724
◽
Keyword(s):
2012 ◽
Vol 13
(16)
◽
pp. 2257-2268
◽